I have written about the vulnerability to various maladies from obesity more times than I can remember. Now, it seems, obesity can result in negative implications attached to COVID-19.
Conditions related to obesity, including inflammation and leaky gut, leave the lungs of obese patients more susceptible to COVID-19 and may explain why they are more likely to die from the disease, UTSW scientists say in a new article published online in eLife. They suggest that drugs used to lower inflammation in the lungs could prove beneficial to obese patients with the disease.
COVID-19, caused by the novel coronavirus SARS-CoV-2, varies widely in clinical severity: Some patients are asymptomatic while others have devastating forms that have led to more than 905,000 deaths worldwide.
Several pre-existing conditions have been shown to increase the risk of COVID-19 severity, including obesity and Type 2 diabetes – two conditions that often go hand-in-hand, says Philipp Scherer, Ph.D., director of the Touchstone Center for Diabetes Research and a professor of internal medicine and cell biology at UT Southwestern.
Wellness Secrets of a SuperAger 
I did see studies early on that showed a high correlation between a high BMI and COVID-19 morbidity.
Recently I saw a study by a large hospital that showed the highest correlation between morbidity and kidney disease. High BMI for 4th or 5th on their list. But the study was more of a report of what they saw in their hospitals.
This thing will take you down if you are young and healthy. If you have any co-morbidity it just decreases your chances of survival and full recovery.
LikeLiked by 1 person
Thanks for sharing. This is fascinating if not very pleasant to learn about. You are exactly right about vulnerability.
LikeLike